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Abstract
Agriculture is the largest contributor to the economies of many African countries, generating
more than half of the annual Gross Domestic Product (GDP) for many of these countries. The
livelihoods of most rural and low-income communities in these countries are to a large extent
based on agriculture. While global availability of food has increased, 35% of the 800 million
poor of the world live in Africa, and face food insecurity. And yet agriculture constitutes, for the
majority of these poor, the primary means of survival and livelihood sustenance. Agricultural
biotechnology, which comprises a wide range of biological disciplines, offers enormous potential
to speed up the development of plant varieties with pro-poor traits such as drought tolerance,
pest resistance or tolerance, higher yields, increased nutritional value, among others. Similarly
in animal production there is substantial opportunity for development of vaccines and diagnostics
targeting diseases which constrain livestock production in developing regions of the world. In
addition, genetic markers can aid breeding of livestock for important traits such as disease
resistance, improved product quality as well as improved productivity. However, to date, the
innovation essential to achieve these improvements has largely remained a technology of the
North. While biotechnology does not provide the ‘silver bullet’ for poverty alleviation, it does
enhance the effectiveness of other disciplines such as plant breeding, integrated pest and nutrient
management, and livestock breeding, feeding and disease management. Importantly, because use
of these technologies, as any other, is associated with risks, African scientists need to have access
to the knowledge and scientific infrastructure to assess these risks and to contribute to better
informed public discussions of the opportunities and challenges of these technologies. Should
biotechnology be a preserve for the rich? Can developing nations afford to ignore the potential of
biotechnology? Rather than debate on whether biotechnology can meet the needs of the poor,
this paper argues that being just one aspect of a complex set of inter-related interventions required
to enhance the contribution of agricultural development to poverty alleviation, discussions should
be had on how best to take advantage of the opportunities and manage the risks associated with
these technologies, for the benefit of the poor. There is need to explore new ways to build the
capacity of the public sector - notably national governments in developing countries and
development partners, as well as to tap into the resources of the private sector - to enable the
continent come up with African solutions to the problem of poverty alleviation. This will require
closer collaboration and transfer, between the North and the South, of appropriate biotechnology
and the management of bio-safety issues. Thus, risk assessment has to be an integral part of
biotechnology research and development. Africa missed out on the ‘Green revolution’, and should
not miss out on the ‘Gene revolution’ as well.
Introduction
Africa remains the world’s poorest continent. Most African countries have economies characterized
by slow and declining growth, low and declining per capita incomes, and declining participation
in the global markets. The limited exports from Africa are predominantly low value commodities,
while hunger, malnutrition and poverty remain widespread in the continent. An estimated 25 to
30 million children are malnourished and the World Health Organization estimates that 54% of
child mortality in African countries is associated with malnutrition. About one-third of the children
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in sub-Saharan Africa are stunted because of poor diet, while thousands of people die each day
from hunger. Another one-third of the continent’s adult population, about 200 million, are food
insecure and are forced to live below their full potential because they lack the energy and full
health to function at their best. If current trends continue, by 2010 Africa would account for
nearly two-thirds of the undernourished people in the world. This vicious cycle of hunger and
poverty needs to be broken.
Agriculture is the most important economic activity in Africa and offers the means to reverse
these trends and to stimulate wider economic growth. This is because 70% of the people in sub-
Saharan Africa live in rural areas and are dependent on agriculture for their livelihoods. However,
African agriculture is performing dismally: crop production is the lowest in the world. Yields of
basic food grains, for example, are one-fifth those of China. Fertiliser use in Africa is 8 kg per
hectare; in Latin America, it is over 60 kg per hectare, and in Asia, over 100 kg per hectare. Only
4% of Africa’s farmland is irrigated; in the Middle East and Asia, the figures are 29% and 34%
respectively. The Green Revolution has had very little effect on the continent’s agriculture in the
last decade or so. In Asia and Latin America, between 60% and 80% of crop area is planted with
modern varieties; in Africa, the figure is between 20% and 30%. As a result, Africa imports more
than 25% of the grain it consumes. Ironically, up to 40% of the continient’s harvest is lost to
post-harvest damage. Moreover, due to rapid increase in human population, there is need to
produce more food on less land, with less water, while conserving the environment.
Although the continent’s GDP has improved over the years, the proportion of people living in
absolute poverty is higher than it was in the 1980s and 1990s (UNDP 2005). While the economies
expanded by 3% per annum between 1990 and 2004, the proportion of Africa’s population
classified as ‘absolute poor’ increased by 2 percentage points every year. It is estimated that it
will take sub-Saharan Africa until 2012 just to restore average incomes to their 1980s levels
(UNDP 2005). There is very limited opportunity for poor people to participate meaningfully in
the economy as either producers of goods and services or as suppliers of labour.
Potential role of biotechnology
Science and technology are recognized globally as drivers of increased wealth and continuously
improving standards of living. The role of science and technological innovation in economic
change and sustainable development is receiving attention at national, regional and international
levels. There is ample evidence that economic advances in the developed and newly industrializing
countries are results of technological and organizational innovations (Mokyr 2002). Scientifically
and technologically advanced countries have become continuously wealthier, and their rates of
growth have not slowed significantly over time (Pritchett 1995). These countries have succeeded
by reinvesting a growing percentage of their gross domestic product (GDP) in further advancement
of research. Translation of research into new, more efficient modes of production has brought
dramatic benefits. Technological innovation is associated with turning scientific knowledge into
products and processes: putting new technologies and their products on the market and
incrementally modifying and adjusting them to respond to socio-economic conditions (Juma
2005). Some of the East Asian countries that capitalized on these opportunities have transformed
themselves into middle- or high-income economies (Nankani 2005). The key to success has been
to focus on improving skills in solving existing and new problems, putting a premium on continuous
learning.
Application of knowledge through new technologies will provide opportunities for improving
developing country economies and the well-being of the people, and offer a means for increasing
agricultural production, improving human health, and addressing environmental degradation. In
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this way it creates economic competitiveness and enhances industrialization. However, these
benefits can only be achieved if countries formulate appropriate policies to facilitate the
development and utilization of requisite human and financial resources and appropriate
infrastructure and functioning support institutions.
In agriculture, advances in biotechnology have resulted in improved research leading to: drought
resistant crop varieties; increased pest and disease resistance in crops and livestock; new, refined
diagnostics and vaccines for livestock diseases (e.g. Foot-and-Mouth disease and East Coast
fever); rapid propagation of clean planting material (e.g. flowers, vegetables, bananas etc.).
Current constraints to the research and application of biotechnology in developing countries
include: lack of policies; lack of human and financial resources; lack of public and private
investments at levels that can make a difference; absence of systems for the delivery of technologies
to potential users; lack of awareness, leading to misconceptions about the potential of, and risks
posed by, biotechnology.
What is the evidence that biotechnology can benefit
developing countries?
There is now ample evidence to demonstrate the opportunities offered by biotechnology in
developing economies, and from which Africa should learn. Two examples are given here, from
China and India.
China
In the early 1980s Chinese leaders decided that science and technology (S&T), especially
biotechnology, would be one of the drivers to improve the agricultural sector, and committed
substantial public investments in biotechnology, e.g. rice biotechnology (mapping rice genome)
and rice breeding (to develop hybrid rice varieties), cotton biotechnology for insect resistance,
production of value-added horticultural crops, and complimentary innovations such as use of
nematodes for biological pest control leading to increased export markets. Currently, hybrid rice
accounts for over 30% of rice in China and over 5 million small farmers are growing Bt-cotton
on 1 million hectares of land. Use of biological control has reduced pesticide use on cotton by
30% nationally. Today, horticultural exports are expanding. Thus, through a deliberate effort to
revolutionize agriculture, China is making quantum leaps in agricultural productivity and
sustainability improvements. The country is now moving to the ‘post-Green Revolution era’
towards becoming an industrialised nation. As has been pointed out above, an efficient agricultural
sector ensures food security and enables industrial development.
India
India’s National Dairy Development Board (NDDB) oversees improved dairy production by
millions of smallholder livestock producers, including many women. Success in using increased
milk production to generate increased income on a daily basis is the result of investments in S&T
targeting: improved feeding and nutrition of dairy cattle; vaccines to control endemic diseases;
and improved animal genotypes and their delivery to farmers. The NDDB organizes delivery of
services (including biotechnologies) at the points of milk collection. Payments for technical
services are affordable and deducted from milk payments to smallholders. In the 1960s and
1970s India regularly had famines and was a net food importing country. The Green-Revolution
in crops and the White Revolution in dairy production are the result of investments in S&T and
infrastructure, especially irrigation and communications and the formulation and implementation
of supportive public policies (prices, trade etc.) to encourage farmers to go into production. India
is now using its productive agricultural sector to guarantee food security and is moving towards
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industrialisation. Although there are still millions of people living in poverty in South Asia the
trends in India and some of its neighbours are heading in the right direction, with millions moving
out of poverty each year.
Livestock and poverty impacts: Role of science and
technology
Livestock products have for generations been known to be a pathway for income generation by
the poor. There is also evidence that small-scale livestock income plays a disproportionately
high role in the income sources of poor rural women and other disadvantaged groups in most
parts of the developing world (von Braun and Pandya-Lorch 1991). Demand for food products of
animal origin is expected to increase dramatically in developing countries (Delgado et al. 1999).
The consumption of meat and milk, for example, is projected to grow at 2.9% and 2.7% per
annum respectively, between the late 1990s to 2020. This ‘livestock revolution’ is also expected
to result in increases in demand for pork (60%), poultry meat (80%) and red meat (50%) by
2020, with developing countries accounting for two-thirds of global meat consumption and more
than half of global milk consumption. The trends in consumer demand for livestock products are
driven primarily by growth in human population, increases in income and urbanization and
associated changes in consumption patterns. In East Asia, even lower income rural households
have begun to shift increasingly to food consumed outside the home, as they have elsewhere in
urban areas of the developing world, which typically involves consuming larger amounts of
higher quality animal products (Gale et al. 2005).
In Africa, livestock production remains largely in the hands of small-scale farmers who collectively
keep approximately 70% of total livestock units. Given this concentration of livestock production,
the potential for a viable industry built around these producers provides a significant opportunity
for them to escape poverty while supplying the consumer demand. Diseases sharply reduce the
productivity of livestock. Conservative estimates of annual losses of US$ 4 billion in meat and
milk production have been reported for sub-Saharan Africa—representing approximately one-
fourth of the total value of livestock production. These losses have a significant impact both on
food security and poverty. Apart from the zoonotic diseases (such as tuberculosis and Avian
influenza) that also afflict poor people, who are in constant contact with different livestock
species, there are also a number of other livestock diseases (such as Foot-and-Mouth disease,
contagious bovine pleuropneumonia, Rift Valley fever and African Swine fever) which preclude
livestock and livestock products of the poor from markets.
Concerns about animal disease transmission keep global livestock to less than 10% of the value
of global production, whereas it is 40% for fish, a commodity with equally great food safety
issues and where trade is overwhelmingly from the developing to the developed countries (Delgado
et al. 2003). Implications of animal health issues on trade are, today, receiving increasingly high
prominence at a time when developing country producers are recognizing expanded opportunities
for international trade in livestock and livestock products. The stakes in effective disease control
in developing countries and reliable ‘point of transaction diagnostics for disease-free-status
certification’ have risen considerably as producers in many of these countries have become aware
of the possibility of export as an addition to what had been relatively less attractive domestic
markets. This is affecting not only those producers immediately capable of supplying export
markets, but is also having an impact on all other producers in the these regions. The negative
impact of border closures in the Middle East due to an outbreak of Rift Valley fever (RVF) on the
price of livestock in the remotest areas of East Africa (Nin-Pratt et al. 2005) is a case in point.
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Technological change in animal disease control with associated policy reforms could bring about
a major shift in the distribution of world livestock production in favour of developing countries
with abundant labour and land resources (Rich 2005). Beyond the development and application
of technologies (such as vaccines and diagnostics) to improve animal health and food safety for
trade, there is also need for market and policy research to demonstrate the high costs of compliance
with traditionally accepted norms and to evaluate the costs and benefits of alternative options for
reducing risk of disease transmission, some of which may be more appropriate to particular
developing country situations.
Livestock biotechnologies and poverty: Opportunities for
Africa
Animal health
Building on a good understanding (based on cumulative knowledge from within and without the
continent) of the biology of livestock (hosts), disease vectors and pathogens, research on animal
health in Africa should focus on the development of technologies to address the constraints
posed by major livestock diseases in the continent to reduce losses (so as to secure the livestock
assets), improve productivity and facilitate access to markets (domestic, regional and global).
As pointed out above, diseases such as contagious bovine pleuropneumonia (CBPP), rinderpest,
Newcastle disease (ND), RVF, trypanosomosis, gastrointestinal nematodes, tick-borne diseases
(such as East Coast fever (ECF), Heartwater and African Swine fever (ASF)), inter alia, continue
to present significant challenges for livestock keepers particularly the poor small-scale farmers.
These diseases affect intensification, productivity and trade. In terms of interventions, while
regulatory measures and cost-effective technologies for disease control have been effective in
developed countries, this has not happened in Africa.
Rapid advances in classical and molecular epidemiology, molecular biology, immunology and
such new sciences as genomics, bio-informatics and proteomics are providing new technological
options that can be applied for the control or eradication of animal diseases in Africa. Some of
these technologies are on the threshold of being developed into effective new tools such as
diagnostics and vaccines, and investment is required in applied research to facilitate this process.
For some diseases, for instance, ND (vaccines), ASF (diagnostics) and ECF (vaccines) progress
towards developing effective products is at stages where probability of success is high with only
modest investments. Conversely, CBPP (vaccines and diagnostics) requires a two-pronged
approach: a quick-win option to improve current vaccines and diagnostics and medium- to longer-
term research to generate improved and more sustainable ‘new generation’ products.
Most, if not all, of the investment in research and development (R&D) relating to the above
diseases has been obtained from public sources in developed countries with a fair amount of up-
stream activities undertaken in the North. However, many of these diseases, e.g. ASF, ECF,
CBPP, RFV, trypanosomosis, among others, have little relevance to the developed world and are
unlikely to be of continuing interest to development partners in the North, except for scientific
curiosity. In the case of ECF vaccine research, a substantial international effort has contributed
to the progress toward proof-of-concept for a vaccine. Nonetheless, funding for completion of
current and subsequent steps of R&D is not guaranteed. Similarly, research on short-term options
for CBPP has benefited from some ‘external’ funding but there has not been adequate and sustained
funding to increase the likelihood of success.
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It is increasingly becoming imperative for Africa not only to define the continent’s R&D agenda
for livestock health but also to mobilize the required resources, including allocation of national
resources, to implement the agenda. Recent technological advances, many already being
successfully applied to address human and animal health problems in the North and, indeed in
some developing countries in Asia and Latin America, provide opportunities which Africa needs
to capture. The level of commitment will be needed both to support quick win options that will
translate into products and strategies (such as the Pan-African Rinderpest Campaign initiative,
improving the ND vaccine, developing ASF diagnostics, improving current CBPP vaccines and
diagnostics) in the shorter term, but also to support medium- to longer-term R&D initiatives.
For some of the disease constraints, there are existing technologies previously developed and
working for similar diseases or those developed for the same diseases but under different settings
(e.g. pathogen strains, delivery infrastructure etc.) elsewhere. In these cases focus should be on
the adaptation of these existing technologies to optimize their use or to enhance their strategic
relevance to a wider range of users and production systems. In marginal areas, animal health
constraints will need to be addressed through a strategy that combines disease control (through
development of appropriate vaccines and diagnostics) and use of appropriate livestock genotypes
(which combine productivity and adaptability to local environmental stresses). Conversely, in
the rapidly changing sub-sectors, such as smallholder dairying in higher potential areas where
exotic breeds and crossbred livestock are predominant, technological interventions need to focus
on reducing disease risks and improving animal productivity taking advantage of the more benign
environmental conditions.
Genetic improvement of  livestock
There is little known about the genetic diversity in indigenous livestock breeds and potential for
genetic improvement in developing countries. To improve utilization of these resources,
information is needed on: how much diversity exists in specific populations; uniqueness of
populations; what breeds/populations to conserve; what conservation methods to apply; and
how the genetic diversity in indigenous breeds can be utilised to generate greater benefits for the
poor livestock keepers, without compromising the diversity. There are no working models for
livestock genetic improvement in low input systems in developing countries, nor true equivalents
of the seed systems that have been critical for the success in crop production. Furthermore, given
the time required to effect genetic change in livestock, it is even more critical that development
of breeding objectives take into account ongoing evolution in the production systems, hence
there is need to understand the system changes and the key drivers. Indeed, it is now well accepted
that, while ex situ approaches can support conservation of livestock diversity, a sustainable strategy
has to be one in which the diversity is dynamically maintained as a functioning part of the
production system. This underscores the need for strategies and breeding technologies that take
the issues of systems changes and links to ‘genotype-evolution’ into account. Progress in livestock
species genome sequencing is opening new ways for the identification and improved understanding
of economically important traits and genes. These developments are catalysing the emergence of
new tools (e.g. bioinformatics and gene expression units, such as micro-arrays) the applications
of which represent new opportunities with significant potential for gene discovery research.
These are common technologies for both vaccine research (e.g. antigen identification) and genetic
improvement. These new technologies are providing newer, faster and possibly more efficient
ways to achieving the same objectives (e.g. a specific breeding goal) and exemplify ‘value addition’
to, rather than replacement of, ‘traditional technologies’, by new technologies. There are many
international efforts focusing on gene discovery for productivity traits in livestock. Efforts in
Africa should focus on adaptive traits needed for the unique circumstances in the continent (e.g.
disease resistance), adapting and applying methodologies developed in the North to speed the
realization of desired outcomes and achievement of impact at local levels. For diseases such as
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helminthosis, which affect livestock (especially small ruminants) across the world, there are
good prospects for global partnerships.
Feeds and nutrition
Most African livestock production is under traditional systems in which feeding and nutrition is
dictated by climatic factors. Thus, there are large cyclical swings in feed availability and quality
closely following the rainfall patterns. During a large part of the year, there is inadequate feed
and the nutritive quality of whatever is available is generally too poor to support animal
maintenance, much less production; a common problem is low protein and high fibre content.
There are a number of biotechnologies which use micro-organisms to ‘bio-process’ feeds/foods
with a view to improving nutritional quality, including digestibility. Important feed ingredients
such as maize and soya which are commonly used in monogastric feeds can also be nutritionally
enhanced through genetic manipulation. Specifically, marker-based technologies are increasingly
used to understand the genetic diversity in forages and in food-feed crops; the technology also
has potential use in food-feed crops in ways that ensure that food yields and qualities are preserved
or enhanced while at the same time improving the feed attributes.
Institutional arrangements to develop and deliver technologies
For both vaccine development and genetic improvement, lack of a working institutional
arrangement to facilitate technology development and delivery can be a major impediment. The
nature of these technologies requires the engagement of a large number of stakeholders, usually
necessitating complex partnership arrangements, not made any easier by need for biosafety and
intellectual property management. Consortia or networks of strategic international collaborators
(including public research institutions in the North and the private sector) and national partners
are almost invariably essential for success. Given the cost involved in putting together such
consortia, it is advisable that, while the initial goal may be quite specific, their designs allow the
flexibility to address other similar technological constraints. This is the basis of the concept of
‘generic research platform’ whose aim is to ensure that the best practices (at both technical and
institutional levels) can be applied more broadly, for example, in the case of livestock, to multiple
diseases, animal genetic resources and in other regions of the world under different settings. The
nature of these platforms may vary considerably and will depend on the scope, focus on addressing
a national or an international problem. An example of an innovative institutional arrangement of
this type is a new initiative known as the Biosciences eastern and southern Africa (BecA).
BecA, an ILRI-NEPAD (New Partnership for Africa’s Development) initiative, is a joint venture
involving NEPAD, ILRI and stakeholders of countries in the sub-region. It is providing a platform
of shared state-of-the-art research facilities and capacity for application of biosciences in
agriculture. The generic nature of the technologies and the partnerships and institutional
arrangements are allowing ILRI to expand the impact of its expertise—in such areas as
immunology, molecular epidemiology and animal genetics—and research outputs focusing on
what gets done rather than just what ILRI does, including availing research capacity beyond
what is needed just for livestock research. The vision is to enable African scientists and institutions
to become biotechnology innovators as well as technology users. This is to be accomplished
through the conduct of biosciences research and innovation targeted at issues affecting Africa’s
development, while accessing and using the best of science available worldwide. The shared
research platform hosted by ILRI is open to African scientists—including those from universities
and national research institutes—and researchers from the broader international community willing
to collaborate with African partners to address African agricultural constraints.
Another example is a recent initiative known as the Global Alliance for Livestock Vaccines and
Diagnostics (GALV), the purpose of which is to establish and support public private partnerships
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that will speed the development and delivery of vaccines and diagnostic products for use by poor
livestock keepers in low income developing countries. It will do this by focusing on promising
leads and aiming to develop these into useful pro-poor animal health products. The initiative is
borne out of the recognition that academia and the donor community alone lack the expertise,
experience and key technology required to turn promising leads, such as vaccine candidates, into
new products for less developed countries through the complex and highly regulated development
process. However, the private sector, whether big pharmaceutical companies or small
biotechnology companies, usually do not have incentive to take on the expensive research and
development programmes themselves for markets that are unlikely to provide a return on
investment.
Conclusion
Economic development in Africa will, of necessity, have to be initially linked to agriculture
(broadly defined to include crop, livestock, forestry and fish). Staple crops and livestock are the
most likely to promote economic growth in the continent. To date, public sector investment in
biotechnology in Africa has led to few products. This has, in part, been due to lack of viable
private sector partners who are able and willing to take new products to markets. There is also a
critical need for innovative public/private sector partnerships which will help link public
investments in R&D with private ‘know-how’ and technology for product development. However,
similar to what is happening in Asia and Latin America, there is great opportunity for Africa to
mobilize science to create wealth for its people and achieve higher economic growth. This requires:
strategic investments in science and technology, with time scales in the range of 20 years (from
discovery to delivery); investment in physical, human and financial resources to build indigenous
science and technology capacity (human and infrastructure); political will to commit the required
resources to develop the requisite capacity and to provide a supportive policy environment;
vibrant private sector, including facilitating emergence of a critical mass of innovative and
enterprising smallholder farmers. In the short-term, some benefits are possible in Africa from
previous discoveries, when adapted and adopted in the African context (e.g. Bt cotton). In the
longer-term, there will have to be local innovations that focus on critical constraints in Africa
(e.g. endemic diseases of livestock).
For biotechnology to create wealth, at least the following must happen: there has to be a clear
definition of priorities/targets (participatory research can assist in target identification); the best
of relevant science regardless of where it comes from around the world must be mobilized and
adapted to address the identified targets (a mechanism for proactive identification of new, relevant
science must be put in place); and a critical mass of resources (human and financial) must be
available for the targets to be met. In addition, the local private sector and communities need to
be involved in product development and commercialization so that new technologies can be both
affordable and accessible. Further, more delivery mechanisms have to be developed so that new
(bio) technologies are accessible to those who need them. Lessons from the rapid uptake of
mobile phone technology in developing countries are pertinent: if a new technology is useful and
the price is right, the spread is almost unstoppable. Clearly, biotechnology is not a substitute for
other technologies, but is an additional arsenal which should be used as and when appropriate to
increase the pace of agricultural development. It is simply another arrow in the quiver!
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